CB
CRSP icon

Community Bank’s CRISPR Therapeutics CRSP Stock Holding History

Community Bank’s Portfolio CRSP Stock Details CRSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.73K Hold
50
– – ﹤0.01% 512
2026
Q1 		$2.38K Hold
50
– – ﹤0.01% 482
2025
Q4 		$2.62K Hold
50
– – ﹤0.01% 472
2025
Q3 		$3.24K Hold
50
– – ﹤0.01% 484
2025
Q2 		$2.43K Hold
50
– – ﹤0.01% 366
2025
Q1 		$1.7K Hold
50
– – ﹤0.01% 370
2024
Q4 		$1.97K Hold
50
– – ﹤0.01% 376
2024
Q3 		$2.35K Hold
50
– – ﹤0.01% 374
2024
Q2 		$2.7K Hold
50
– – ﹤0.01% 389
2024
Q1 		$3.41K Buy
+50
New +$3.58K ﹤0.01% 389

Other funds holding CRSP

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GP
GSK plc London $602M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Community Bank's CRSP Position: Q2 2026 in Review

Community Bank held its CRISPR Therapeutics (CRSP) position steady in Q2 2026 at 50 shares worth $2.73K. The position accounts for ﹤0.01% of the portfolio, ranked #512.

Community Bank first reported a position in CRSP in Q1 2024 and has held it in 10 quarters since. The position peaked at $3.41K in Q1 2024. 521 funds tracked by Wall St. Rank hold CRSP as of Q2 2026.

  • Community Bank held 50 shares of CRISPR Therapeutics worth $2.73K as of Q2 2026.
  • Community Bank left its CRISPR Therapeutics share count unchanged in Q2 2026.
  • CRISPR Therapeutics made up ﹤0.01% of Community Bank's portfolio in Q2 2026, its #512 holding.
  • Community Bank first reported a position in CRISPR Therapeutics in Q1 2024 and has held it in 10 quarters since.
  • Community Bank's CRISPR Therapeutics position peaked at $3.41K in Q1 2024.
  • 521 funds tracked by Wall St. Rank held CRISPR Therapeutics as of Q2 2026.

Based on Community Bank's 13F filing for Q2 2026, filed 13 Aug 2026.